IntelGenx Technologies (IGXT) 10-Q2019 Q1 Quarterly report

Filed: 9 May 19, 4:02pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigious
Readability	H.S. freshman Avg

New words: accelerated, andTopic, appointed, approach, area, arrangement, borrowing, brokerage, budgeting, CA, Center, CEO, chain, check, checkmark, Chemistry, cited, Codification, confirmed, Consortium, construction, cooperate, court, CRL, Dec, dementia, differentiated, discount, discounted, du, dysfunction, ED, edited, emerging, Employer, erectile, expert, expertise, external, filer, focused, founder, FRCPC, Gauthier, guide, hindsight, honoured, Hospital, identification, incremental, Institute, Interaction, internationally, investigator, investor, issuer, Japan, Japanese, jointly, journal, JPO, Knight, La, large, Le, lean, life, maladie, mark, McGill, MD, Medicine, member, Mental, minimum, modified, moment, National, network, neurologist, Neurology, Neurosurgery, noncancelable, Obeid, Ordre, oversee, polymeric, Professor, progressive, Psychiatry, registrant, remeasurement, renewal, requested, requesting, responding, restated, resubmitted, revised, Rodolphe, role, Rule, Senior, Serge, serve, served, shortly, smaller, solve, specialty, split, strong, tadalafil, technical, tenor, terminated, termination, textbook, titled, undiscounted, University, Washington, wholly

Removed: aborted, acceptable, acquired, AFS, allocate, amortized, AOCI, apply, assessing, assessment, Bupropion, collect, combination, commonly, computer, determinable, disclosing, distinct, DTA, evaluate, exercisable, explain, explanation, extensive, good, goodwill, hydrochloride, inception, insurance, intent, invoking, iv, key, laboval, launch, leasing, longer, make, modification, monetization, negative, negatively, paragraph, perform, practicability, promised, qualitative, realizability, Reclassification, reclassify, recognizing, record, recovered, recovering, recovery, refundable, represented, Simplifying, step, stranded, strength, targeted, terminology, test, transparency, Wellbutrin, XL®

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

IGXT similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of IntelGenx Technologies Corp. (the "Company") on Form 10-Q for the period ending March 31, 2019, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), I, Andre Godin, Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Sec. 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge and belief:

(1) The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

/s/ Andre Godin

- ------------------------------

Andre Godin

Principal Accounting Officer

May 9, 2019

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request. The foregoing certifications are accompanying the Company's Form 10-Q solely pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18, United States Code) and is not being filed as part of the Form 10-Q or as a separate disclosure document.